Co-Authors
This is a "connection" page, showing publications co-authored by Jawed Fareed and Alfonso Tafur.
Connection Strength
1.674
-
The Risk of Venous Thromboembolism is Not Equal for all Patients Who Undergo Total Joint Replacement. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619838062.
Score: 0.802
-
An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost. 2021 Jan-Dec; 27:10760296211021498.
Score: 0.230
-
Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020. Clin Appl Thromb Hemost. 2020 Jan-Dec; 26:1076029620936350.
Score: 0.215
-
Factor Xa Inhibitory Profile of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban Does Not Fully Reflect Their Biologic Spectrum. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619847524.
Score: 0.201
-
The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper. Thromb Haemost. 2021 Aug; 121(8):992-1007.
Score: 0.060
-
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine. Thromb Haemost. 2020 Dec; 120(12):1597-1628.
Score: 0.056
-
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost. 2020 Jul; 120(7):1004-1024.
Score: 0.055
-
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 06 16; 75(23):2950-2973.
Score: 0.055